Skip to content

Using lung ultrasound to diagnose pulmonary tuberculosis: evaluating scanning methods and the ultrasound probes for accuracy in Zambia

Lung ultrasound in pulmonary tuberculosis: evaluating image acquisition protocol-and-probe accuracy in Zambia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN80646876
Enrollment
2600
Registered
2024-12-13
Start date
2025-09-08
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary tuberculosis Infections and Infestations

Interventions

This is a randomised diagnostic study. Consenting presumptive tuberculosis patients will be randomised to one of four lung ultrasound image acquisition protocol/probe combinations: 1. Comprehensive pr

Sponsors

NIHR Global Health Research Programme
Lead Sponsor
Delft Diagnostics
Collaborator
Wellcome Trust
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age 18 years and older consenting to enrolment 2. Presenting to the outpatient department, TB clinic, or ART clinic with symptoms suggestive of TB (cough>2 weeks plus at least one additional symptom including fever, night sweats, weight loss, or haemoptysis)

Exclusion criteria

Exclusion criteria: 1. Inability (or refusal) to give written informed consent 2. Current in-patient 3. Too unwell or unwilling to undergo study procedures 4. Known microbiologically confirmed PTB

Design outcomes

Primary

MeasureTime frame
The diagnostic accuracy of LUS for PTB relative to Xpert® MTB/RIF Ultra will be measured using sensitivity and specificity for each protocol/probe combination at a single timepoint (baseline). A positive LUS is one that will have the presence of subpleural consolidation or consolidation or pathological B-line Sensitivity of LUS = true TB positives /true positives + false negatives (relative to GeneXpert) Specificity of LUS = true TB negatives/true TB negatives+ false TB positives (relative to GeneXpert)

Secondary

MeasureTime frame
1. Sensitivity of LUS in HIV-positive compared with HIV-negative individuals: Sensitivity will be measured using the proportion of true positive cases correctly identified by lung ultrasound (LUS) in both HIV-positive and HIV-negative individuals. Measurements will be taken at baseline (single timepoint) 2. Specificity of LUS in patients with previous PTB compared with patients without previous PTB: Specificity will be measured using the proportion of true negative cases correctly identified by LUS in patients with and without previous pulmonary tuberculosis (PTB). Measurements will be taken at baseline (single timepoint) 3. LUS features predictive of PTB: Predictive features will be identified through human reader analysis of LUS images (specifically for the presence/absence of subpleural nodules, consolidations, cavities, pleural irregularities, and pathological B-lines). Measurements will be taken at baseline (single timepoint) and the sensitivity and specificity of each of these LUS features measured individually, as in 1 and 2 above.

Countries

Zambia

Contacts

Public ContactJohn Kondwelani;Helen Mateyo;Ayles

;

john.mateyo@lshtm.ac.uk;helen@zambart.org.zm+44 (0)260966611097;+44 (0)260966746796

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026